Literature DB >> 34076600

Clinical predictors and prognostic role of high Killip class in patients with a first episode of anterior ST-segment elevation acute myocardial infarction.

Marco Giuseppe Del Buono1, Rocco A Montone2, Riccardo Rinaldi1, Filippo Luca Gurgoglione1, Maria Chiara Meucci1, Massimiliano Camilli1, Giulia Iannaccone1, Tommaso Sanna2, Daniela Pedicino2, Carlo Trani2, Giampaolo Niccoli1,2,3, Filippo Crea1,2.   

Abstract

AIMS: Killip classification is a simple and fast clinical tool for risk stratification of patients presenting with acute coronary syndrome (ACS). However, the clinical features and predictors of high Killip class at admission, and its prognostic impact in patients presenting with anterior ST elevation MI (STEMI) as first clinical cardiovascular event are still poorly known. The aim of this study was to identify the predictors of high Killip class and its impact on in-hospital and follow-up outcomes.
METHODS: We prospectively enrolled patients with unheralded anterior STEMI because of proximal or mid left anterior descending (LAD) artery categorized according to Killip classification. Patients' characteristics, in-hospital complications and major adverse cardiovascular events (MACEs; composite of all-cause death, heart failure hospitalization and new-onset ACS) at follow-up were collected.
RESULTS: We enrolled 147 patients [age 66.16±13.33, 113 male patients (76.9%)]. Killip class III--IV occurred in 22 (15%) patients. The median duration of follow-up was 12 [6--15.1] months. At multivariate analysis age [hazard ratio 1.137, 95% CI (1.068--1.209), P < 0.001], prehospital cardiac arrest [hazard ratio 12.145, 95% CI (1.710--86.254), P = 0.013] and proximal LAD lesion [hazard ratio 5.066, 95% CI (1.400--18.334), P = 0.013] were predictive of Killip class III--IV at admission. At multivariate analysis, Killip class III--IV was an independent predictor of in-hospital mortality [hazard ratio 7.790, 95% CI (1.024--59.276], P = 0.047 and of MACEs [hazard ratio 4.155 (1.558--11.082), P = 0.004) at follow-up.
CONCLUSION: Killip classification performed at the time of admission is a simple and useful clinical marker of a high risk of early and late adverse cardiovascular events.
Copyright © 2021 Italian Federation of Cardiology - I.F.C. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34076600     DOI: 10.2459/JCM.0000000000001168

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  4 in total

1.  Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial Infarction.

Authors:  Marco Giuseppe Del Buono; Juan Ignacio Damonte; Juan Guido Chiabrando; Roshanak Markley; Jeremy Turlington; Cory R Trankle; Le Kang; Giuseppe Biondi-Zoccai; Benjamin W Van Tassell; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

Review 2.  Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction.

Authors:  Marco Giuseppe Del Buono; Francesco Moroni; Rocco Antonio Montone; Lorenzo Azzalini; Tommaso Sanna; Antonio Abbate
Journal:  Curr Cardiol Rep       Date:  2022-08-16       Impact factor: 3.955

3.  Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.

Authors:  Yudan Wang; Wenjing Wang; Shengqi Jia; Man Gao; Shihang Zheng; Jiaqi Wang; Yi Dang; Yingxiao Li; Xiaoyong Qi
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

4.  Outcomes of Nonagenarians with Acute Myocardial Infarction with or without Coronary Intervention.

Authors:  Seok Oh; Myung Ho Jeong; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.